Physician profile
Jonathan S Lam
NPI 1598051716
$5,082.06
in general payments reported to CMS, 2019-2025
21 companies · $405 in 2025
The $405 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.82 · 2020: $42.70 · 2021: $61.91 · 2022: $473 · 2023: $2,935 · 2024: $1,108 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,608 · Travel and Lodging: $1,772 · Consulting Fee: $51.91 · Entertainment: $15.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,607.91 |
| Travel and Lodging | $1,772.36 |
| Consulting Fee | $51.91 |
| Entertainment | $15.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $2,079.37 | 2020-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $699.66 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $691.92 | 2023-2025 | |
| Smith+Nephew, INC. | $582.55 | 2022-2025 | Collagenase Santyl, Grafix Pl, Stravix Pl |
| Musculoskeletal Transplant Foundation INC. | $273.88 | 2022-2025 | |
| Lifenet Health | $184.76 | 2023 | |
| Abbott Laboratories | $151.28 | 2022-2023 | Proclaim |
| Allergan, INC. | $67.02 | 2022 | |
| Molnlycke Health Care US, LLC | $63.65 | 2022 | |
| Kci USA, INC. | $49.00 | 2022-2023 | Activ.A.C., Prevena |
| Biocomposites INC | $47.43 | 2023 | Stimulan |
| Kerecis Limited | $27.73 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Avanos Medical | $22.45 | 2019 | |
| Integra Lifesciences Corporation | $22.03 | 2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Bioventus LLC | $21.73 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $19.63 | 2020 | |
| Shire North American Group INC | $18.73 | 2019 | |
| Convatec INC. | $15.64 | 2019 | |
| Motiva USA, LLC | $15.25 | 2025 | |
| Heron Therapeutics, INC. | $14.18 | 2022 | |
| Solventum Corporation | $14.17 | 2024 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.